Abstract
There is tremendous interest of research which surrounds the concept of “osteoporosis,” as shown by the intense and growing research activity in the field. The urgency to advance knowledge in this area is motivated by the need to understand not only the causes, diagnosis and treatment but also need for early identification or detection of this silent disease. Despite the various researches work is going on, important issues remain unresolved. In this paper, Osteoporosis has also been discussed with respect to biological, engineering, biochemical and physical aspects. The diagnostic and therapeutic techniques have been described for osteoporosis, for better health care. The novelty of the review paper lies in clarifying several myths, explaining the disease in details with biomedical engineering aspects and focuses on the several detection techniques, providing a new direction for early diagnosis of this deadly disease and gives new directions for the POCT device for Osteoporosis.
Similar content being viewed by others
References
Arnaud, C. D., 1996, Osteoporosis: Using ‘Bone Markers’ for Diagnosis and Monitoring. Geriatrics, 51, pp. 24–30.
Bal, S. K. and McCloskey, E. V., 2002,Menopause and Bones, Current Obst & Gynaec. 12, pp. 354–357.
Becerra-Rojas, F. and Jupari, M., 2001, Epidemiology of Osteoporosis in Peru Bone, Volume 29, Issue 3, Page 297.
Bagur, A., 2001, Epidemiology of osteoporosis in Argentina Bone, Volume 29, Issue 3, Page 298.
Bianchi, M. L., Cimaz, R., Bardare, M. et al., 2000, “Efficacy and Safety of Alendronate for the Treatment of Osteoporosis in Diffuse Connective Tissue Diseases in Children: A Prospective Study,” Arthritis & Rheum 43, 1960.
Bianchi, M. L., 2005, How to Manage Osteoporosis in Children? Bone Prac. & Res Clinical Rheumatology, Vol. 19, Issue 6, Dec, pp. 991–1005.
Bouxsien, Mary L., 2005, Determinants of Skeletal Fragility, Best Practice & Research Clinical Rheumatology, Vol. 19, No. 6, pp. 897–911.
Carneiro, R. A., 2001, Epidemiological Aspects of Osteoporosis in Brazil Bone, Volume 29, Issue 3, Page 298.
Clemens, J. D. et al., 1997, Evidence That Serum NTx (collgen-type I N teolopeptides) Can Act as Immunochemical Marker of Bone Resorption, Clin. Chem, 43: pp. 2058–2063.
Danielson, M. E., Cauley, J. A., Baker, C. E., Newman, A. B., Dorman, J. S., Towers, J. D. et al., 1999. Familial Resemblance of Bone Mineral Density (BMD) and Calcaneal Ultrasound Attenuation: the BMD in Mothers and Daughters Study, J Bone Miner Res 14, pp. 102–110.
Deal, C. L., 1997. Osteoporosis: Prevention, Diagnosis, and Management, Am J Med. 102 (1A), pp. 35S-39S.
Delmas, P. D., 2002. Treatment of Postmenopausal Osteoporosis. The Lancet. 359, pp. 2018–2026.
Demers, L. M., 1997. Clinical Usefulness of Markers of Bone Degradation and Formation, Scand J Clin Lab Invest. Suppl 227, pp. 12–20.
Eastell, R., 1998, Treatment of Postmenopausal Osteoporosis, N Engl J Med. 338, pp. 736–746.
Eastell, R. and Blumsohn, A., 1997, The Value of Biochemical Markers of Bone Turnover in Osteoporosis, J Rheumatol. 24, pp. 1215–1217.
Faulkner, R. A., Bailey, D. A., Drinkwater, D. T. et al., 1996, Bone Densitometry in Canadian Children 8–17 Years of Age. Calcif Tissue Int 59, pp. 344.
Ferretti, J. L. et al., 2003, Etiopathogenesis of osteoporosis. Mechanism of Ageing & Development. 00, 1–11.
Francisco, Diez DC, 2001, Review of the Literature: Guidelines for the Diagnosis of Osteoporosis by Densitometric Methods, J. Manipulative and Physiological Therapeutic, July/Aug, Vol. 25, Number 6, pp. 403–412.
Gillespy, T. and Gillespy, M. P., 1991, Osteoporosis. Radiol Clin North Am. 29, pp. 77–84.
Gluer, C. C., Jergas, M. and Hans, D., 1997. Peripheral Measurement Techniques for the Assessment of Osteoporosis, Semin Nucl Med. 27, pp. 229–247.
Gordon, C. M., 2000, Mini Review-Bone Density Issues in the Adolescent Gynecology Patient, J Pediatr Adolesc Gynecol, 13, pp. 157–161.
Heineman, W. R., Thomas, J. H., Wijayawardhana, A., Brian Halsall et al., 2001, BioMEMS: Electrochemical Immunoassay with Microfluidic Systems, Analytic Sciences, Vol. 17, Supplement pp. i281-i284.
Hern’andez, E. R., Seco-Durban, C., Revilla, M., Gonz’alez-Riola, J. and. Rico, H., 2003. Evaluation of Bone Density with Peripheral Quantitative Computed Tomography in Healthy Premenopausal, Perimenopausal, and Postmenopausal Women, Age and Ageing, Volume 24, Number 5, pp. 447–450.
Hosking, D., Chilvers, C. E. D., Christiansen, C. et al., 1998. Prevention of Bone Loss with Alendronate in Postmenopausal Women Under 60 Years of Age, N Engl J Med. 338, pp. 485–492.
Isenbarger, D.W. and Chapin, B. L., 1997, Osteoporosis. Current Pharmacologic Options for Prevention and Treatment, Postgrad Med. 101, pp. 129–132.
Jeal, W., Barradell, L. B. and McTavish, D., 1997, Alendronate: a Review of its Pharmacological Properties and Therapeutic Efficacy in Postmenopausal Osteoporosis, Drugs. 53, pp. 415–434.
Jean Hodson and Jen Marsh, 2003, Quantitative Ultrasound and Risk Factor Enquiry Comparative Study in Primary Care Osteoporosis: as Predictors of Postmenopausal. doi: 10.1136/bmj. 326.7401.12502003; 326; pp. 1250–1251 BMJ, 2003 Jean.
Jourdon, K. M., 2002. Epidemiology of Osteoporosis, Best Practice & Res Clin Rhe. 16, pp. 795–806.
Jouanny, P., Guillemin, F., Kuntz, C., Jeandel, C. and Pourel, J., 1995 Environmental and Genetic Factors Affecting Bone Mass. Similarity of Bone Density among Members of Healthy Families, Arthritis Rheum 38, pp. 61–67.
Kanis, J. A., 2002, Diagnosis of Osteoporosis and Assements of Fracture Risk, The Lancet. 359, pp. 1929–1936.
Khovidhunkit, W. and Shoback, D.M., 1999, Clinical Effects of Raloxifene Hydrochloride in Women, Ann Intern Med. 130, pp. 431–439.
Korkia, P., 2002. Osteoporosis: Process, Prevention and Treatment, J. Bodywork & Movement Theparies. 6, pp. 156–169.
McClung, M. R., Geusens, P., Miller, P. D. et al., 2001, Effect of Risedronate on the Risk of Hip Fracture in Elderly Women, N Engl J Med. 344, pp. 333–340.
Melton, L. J. D., Chrischilles, E. A., Cooper, C., Lane, A. and Riggs, B. L., 1992, Perspective: How Many Women Have Osteoporosis? J Bone Miner Res 7, pp. 1005–1010.
Osteoporosis Society of Canada. 2, The Use of Bone Density Measurement in the Diagnosis and Management of Osteoporosis, Can Med Assoc J. 155, pp. 924–929.
Pedra, C. de la et al., 1997, New Biochemical Markers of Bone Resorption in the Study pf Postmenopausal Osteoporosis, Clinical Chimica acta, 256, pp. 225–234.
Raisz, L. G., 1997, The Osteoporosis Revolution. Ann Intern Med. 126, pp. 458–462.
Rapado, A., 2001, Epidemiology of Osteoporosis in Spain, Bone, Volume 29, Issue 3, Page 299.
Recker, R. R., 1994, Bone Biopsy and Histomorphometry in Clinical Practice, Rheum Dis Clin North Am 20, pp. 609–627.
Roux, Sophie, 2001, The Genetics of Osteoporosis, Jt Bone Spine, 68, pp. 482–486.
Sambrook, P. N., Kelly, P. J., Morrison, N. A. and Eisman, J. A., 1994. Genetics of Osteoporosis, Br J Rheumatol 33, pp. 1007–1011.
Samsioe, G., 1997. Osteoporosis-an Update, Acta Obstet Gynecol Scand, 76, pp. 189–199.
Singh, Kanika, 1997, “Electronic Bone Fracture Detector,” Proc IEEE-EMBS Int Conf, Chicago (USA), Oct 29 to Nov 3.
Singh, Kanika, 1998, “Portable battery operated bone fracture evaluator,” Proc IEEE-EMBS Int Conf, Hong Kong, Oct 28 to Nov 3.
Singh, K. and Kim, K. C., 2005, Biomechanics of Bone, Proc. 7th Cross Straits Symposium on Materials, Energy and Environmental Sciences, CSS7, pp. 35–36.
Singh, K., 2004, A Bone-Based Sensor, 26th Annual International Conference for Attending IEEE-EMBS conf., San Francisco, USA, 1–5th Sept.
Singh, Kanika, 1999, “Development of a Dynamic Bone Micro-Sensor for Biomedical Applications,” Proc. IEEE-EMBS Int. Conf., Atlanta, USA, Oct 29-Novl.
Smith, R., 1993, Bone Physiology and the Osteoporotic Process, Respir Med. Feb; 87 Suppl A: 3–7.
Sortis, D. H., 1996, Osteoporosis Diagnosis and Treatment Edited by David J., Copyright by Marcel Dekker, Book, Printed in USA.
Sturtridge, W., Lentle, B. and Hanley, D. A., 1996, Prevention and Management of Osteoporosis: Consensus Statements from the Scientific Advisory Board of the.
Vermeer, C., Gijsbers, B.L., Cracium, A. M. et al., 1996, Effects of Vitamin K on Bone Mass and Bone Metabolism, J Nutrition 126, 1187S.
Takao, H., Miyamura, K. et al., 2004, A MEMS Microvalve with PDMS Diaphragm and Two-Chamber Configuration of Thermo-Pneumatic Actuator for Integrated Blood System on Silicon, Sensor and Actuators A 119, pp. 468–475.
Turner, C. H., 2002, Review Article: Biomechanics of Bone: Determinants of Skeletal Fragility and Bone Quality. Osteoporosis Int (2002) 13: pp. 97–104 2002 International Osteoporosis Foundation and National Osteoporosis Foundation.
Yates, A. J., Ross, P. D., Lydick, E., Epstein, R. S., 1995, Radiographic Absorptiometry in the Diagnosis of Osteoporosis, Am J Med. 98 (2A), pp. 41S-47S.
Yang, G. Y, Vasudev, J. B. et al., 2004, Design of Microfabricated Strain Gauge array to Monitor Bone Deformation In Vitro and In Vivo, Proc. of the Fourth IEEE Symp on Bioinformatice and Bioengineering (BIBE’04).
Yang, G. Y., Bailey. V. J., Wen, Y. H., Tang, W. C. and Keyak, J. H., 2004, Fabrication and Characterization of Microscale Sensors for Bone Surface Strain Measurement, IEEE, pp. 1355–1358.
Zaidi Mone, 2006, Edited, Skeletal Development and Remodeling in Health, Disease and Aging. Boston Mass, Blackwell Pub on Behalf of New York Academy of Sciences, 2006.
Net References
www.nof.org/osteoporosis/images
www.osteomark.org
www.osteofound.org
www.who.org
http://www.iupac.org/publications/pac/1995/ pdf/6711xl929.pdf
http://www.uc.edu/news/NR.asp?id = 3280
www.niams.nih.gov/bone/osteoporosis
www.activella.com/2_3_2.asp
www.medinfo.co.uk
www.fpnotebook.com
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, K., Lee, S.H. & Kim, K.C. Osteoporosis: New biomedical engineering aspects. J Mech Sci Technol 20, 2265–2283 (2006). https://doi.org/10.1007/BF02916343
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02916343